Similarly, Hotter et al. [33], in an attempt to investigate the relationship between blood biomarkers and stroke outcome, concluded that ultrasensitive copeptin may add valuable prognostic information following stroke, as its evaluation was significantly associated with functional outcome at 90 days poststroke. The gene discussed is AVP; the disease is Stroke.